Global Pharmaceuticals & Biotech Most Popular Stocks

Biofrontera

Market Cap: US$10.2m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

TFF Pharmaceuticals

Market Cap: €9.7m

A clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia.

EOM Pharmaceuticals Holdings

Market Cap: US$10.1m

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases.

Evogene

Market Cap: ₪33.8m

Operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

Central Pharmaceuticals

Market Cap: ৳1.2b

Manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh.

Barak Investment House

Market Cap: ₪33.5m

Engages in the managing of investments in the capital market.

Celestra

Market Cap: ₩13.5b

A biotechnology company, provides genome-based cancer and disease diagnostic solutions.

Algorae Pharmaceuticals

Market Cap: AU$15.2m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

KRTL Holding Group

Market Cap: US$9.9m

KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.

Tikun Olam-Cannbit Pharmaceuticals

Market Cap: ₪33.1m

Engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel.

BetterLife Pharma

Market Cap: US$9.9m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

IDL Diagnostics

Market Cap: SEK 92.6m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Source Natural Foods and Herbal Supplements

Market Cap: ₹873.2m

Manufactures and sells ayurveda, health and dietary supplements, and food products in India.

Inhibitor Therapeutics

Market Cap: US$9.8m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

Dogwood Therapeutics

Market Cap: US$9.8m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Processa Pharmaceuticals

Market Cap: US$9.7m

A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.

Ben Tre Pharmaceutical

Market Cap: ₫254.8b

Manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally.

Ind-Swift

Market Cap: ₹850.4m

Develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India.

Pila Pharma

Market Cap: SEK 90.1m

Operates as a clinical stage biotech company in Sweden.

Cizzle Biotechnology Holdings

Market Cap: UK£7.1m

Operates as a cancer diagnostics company in the United Kingdom.

Genesis IBRC India

Market Cap: ₹844.9m

Does not have significant operations.

IN8bio

Market Cap: US$9.5m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

ESSA Pharma

Market Cap: US$9.5m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Genflow Biosciences

Market Cap: UK£7.0m

Engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium.

Onyx Biotec

Market Cap: ₹830.4m

Develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally.

Qualigen Therapeutics

Market Cap: US$9.4m

A clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer.

IM Cannabis

Market Cap: US$9.3m

Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.

Lipigon Pharmaceuticals

Market Cap: SEK 87.6m

Develops drugs for lipid related diseases in Sweden.

Angiolab

Market Cap: ₩13.1b

A biotechnology company, develops medicine with angiogenesis inhibitors for treating angiogenesis-related diseases.

Marvel Biosciences

Market Cap: CA$12.9m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Sunil Healthcare

Market Cap: ₹821.4m

Engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally.

Asston Pharmaceuticals

Market Cap: ₹818.4m

Engages in the manufacturing pharmaceutical products in India, West Africa, South Africa, and Asian countries.

Pharmala Biotech Holdings

Market Cap: CA$12.8m

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Palatin Technologies

Market Cap: US$9.1m

A biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.

Makers Laboratories

Market Cap: ₹807.2m

An integrated pharmaceutical company, manufactures and markets formulations in India.

AEON Biopharma

Market Cap: US$9.1m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.